Endpoints News
FDA commissioner's comment aimed at Hims' GLP-1 pill plans, source says Read in browser
Endpoints News
ALERT
Thank you for reading, dupa dupackia!
basic
UPGRADE
Breaking News

FDA Com­mis­sion­er Mar­ty Makary took a not-so-sub­tle swipe at Hims & Hers in a so­cial me­dia post Thurs­day, say­ing his agency would "take swift ac­tion against com­pa­nies mass-mar­ket­ing il­le­gal copy­cat drugs...

Read the full story
Endpoints News
2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com
web twitter linkedin
Worldwide made. Thanks for reading.
Unsubscribe preferences
Unsubscribe from all newsletters
FT Specialist Logo A service from the Financial Times